SEC Filing Analysis: Quest Diagnostics Inc

Executive Summary

• Trading Significance: Low
• Key Takeaway: Vanguard Group Inc. reports 0% ownership solely due to an internal corporate realignment where subsidiaries now report separately.
• Market Impact: Neutral - This is a technical reporting change, not a liquidation of the underlying assets.

Company Information

Field	Value
Company	Quest Diagnostics Inc
CIK	0001022079
Industry	Services - Medical Laboratories
Market Cap	$21.45 Billion

Insider Information

Field	Value
Name	The Vanguard Group
CIK	0000102909
Type	Investment Adviser
Location	Malvern, PA

Transaction Details

Field	Value
Form Type	SCHEDULE 13G/A
Event Date	2026-03-13
Shares Owned After	0
Percent of Class	0%
Ownership Type	N/A

Financial Impact Assessment

Transaction Materiality

• Transaction Value: N/A (Technical Update)
• Materiality Assessment: Low

Impact Evaluation

• Market Cap Context: As a $21.45B Large Cap company, Quest Diagnostics has significant institutional backing. This filing alters how that backing is reported (disaggregated) rather than if it exists.
• Ownership Concentration: While the parent entity "The Vanguard Group" reports 0 shares, the actual shares are likely still held by Vanguard subsidiaries/funds, meaning the effective float reduction remains similar.
• Transaction Significance: The filing explicitly states: "The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries."

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The reduction to 0% is administrative. Investors should expect subsequent filings from Vanguard subsidiaries (e.g., Vanguard Index Funds) that will collectively account for the holdings previously reported by the parent.

Volume & Sentiment

• Expected Volume Impact: Negligible.
• Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

• Internal Realignment: On January 12, 2026, Vanguard underwent a realignment allowing subsidiaries to report separately in reliance on SEC Release No. 34-39538.
• Reporting Change: This filing closes the reporting loop for the parent company regarding these specific securities.